{
  "description": "臺灣衛生福利部中央健康保險署「給付適應症」代碼，代碼出版日期：2025-07-01；資料所屬單位：臺灣衛生福利部中央健康保險署。",
  "_filename": "CodeSystem-nhi-apply-reason.json",
  "package_name": "tw.gov.mohw.nhi.pas",
  "date": "2025-07-01",
  "publisher": "衛生福利部中央健康保險署",
  "content": "complete",
  "name": "NHIApplyReason",
  "type": null,
  "experimental": "false",
  "resourceType": "CodeSystem",
  "title": "NHI-健保事前審查-給付適應症",
  "package_version": "1.0.5",
  "status": "active",
  "id": "dc08408f-6733-430b-ad79-e56e999ef1de",
  "kind": null,
  "count": 25,
  "url": "https://nhicore.nhi.gov.tw/pas/CodeSystem/nhi-apply-reason",
  "concept": [ {
    "code": "C50P1",
    "display": "早期乳癌-未發生腋下淋巴結轉移",
    "definition": "事前審查品項代碼為KC010892B5、KC011162B5、JC00154261、KC009612B5(自113年12月擴增)、KC011112DE(114年1月起擴增)才可填寫"
  }, {
    "code": "C50P2",
    "display": "早期乳癌-具腋下淋巴結轉移",
    "definition": "事前審查品項代碼為KC009612B5、KC010892B5、KC011112DE、KC011162B5、KC011362B5、JC00154261才可填寫"
  }, {
    "code": "C50R1",
    "display": "轉移性乳癌",
    "definition": "事前審查品項代碼為KC009612B5、KC010892B5、KC011112DE、KC011162B5、KC011362B5、JC00154261才可填寫"
  }, {
    "code": "C16R1",
    "display": "轉移性胃癌",
    "definition": "事前審查品項代碼為KC009612B5、KC010892B5、KC011112DE、KC011162B5、KC011362B5、JC00154261才可填寫"
  }, {
    "code": "P001",
    "display": "黑色素瘤",
    "definition": "事前審查品項代碼為KC01013229、KC01013230、KC01025219才可填寫"
  }, {
    "code": "P011",
    "display": "非小細胞肺癌-SQ-2線",
    "definition": "事前審查品項代碼為KC01050238、KC01013229、KC01013230、KC01025219才可填寫"
  }, {
    "code": "P012",
    "display": "非小細胞肺癌-Adeno-3線",
    "definition": "事前審查品項代碼為KC01050238、KC01013229、KC01013230、KC01025219才可填寫"
  }, {
    "code": "P013",
    "display": "非小細胞肺癌-1線",
    "definition": "單用或併用，114年6月起擴增。事前審查品項代碼為KC01050238、KC01025219才可填寫(114年1月起擴增)"
  }, {
    "code": "P014",
    "display": "鱗狀非小細胞肺癌第一線用藥(併用化療)",
    "definition": "事前審查品項代碼為KC01025219才可填寫"
  }, {
    "code": "P021",
    "display": "小細胞肺癌(併用化療)",
    "definition": "事前審查品項代碼為KC01050238、KC01088229才可填寫"
  }, {
    "code": "P031",
    "display": "典型何杰金氏淋巴瘤",
    "definition": "事前審查品項代碼為KC01013229、KC01013230、KC01025219才可填寫"
  }, {
    "code": "P041",
    "display": "泌尿道上皮癌-2線",
    "definition": "事前審查品項代碼為KC01013229、KC01013230、KC01025219、KC01050238(113/8/1停止新病人給付)才可填寫"
  }, {
    "code": "P042",
    "display": "泌尿道上皮癌-1線",
    "definition": "事前審查品項代碼為KC01025219、KC01050238(113/8/1停止新病人給付)才可填寫"
  }, {
    "code": "P043",
    "display": "局部晚期或轉移性泌尿道上皮癌之維持療法",
    "definition": "事前審查品項代碼為KC01085229才可填寫"
  }, {
    "code": "P052",
    "display": "胃癌-1線(併用化療)",
    "definition": "事前審查品項代碼為KC01013230才可填寫"
  }, {
    "code": "P061",
    "display": "腎細胞癌",
    "definition": "事前審查品項代碼為KC01013229、KC01013230才可填寫"
  }, {
    "code": "P072",
    "display": "晚期肝細胞癌-1線(併用標靶bevacizumab)",
    "definition": "事前審查品項代碼為KC01050238、KC01088229才可填寫"
  }, {
    "code": "P081",
    "display": "頭頸部鱗狀細胞癌第二線用藥",
    "definition": "事前審查品項代碼為KC01013229、KC01013230、KC01025219才可填寫"
  }, {
    "code": "P082",
    "display": "頭頸部鱗狀細胞癌第一線用藥",
    "definition": "事前審查品項代碼為KC01025219才可填寫"
  }, {
    "code": "P091",
    "display": "默克細胞癌",
    "definition": "事前審查品項代碼為KC01085229才可填寫"
  }, {
    "code": "P101",
    "display": "食道鱗狀細胞癌",
    "definition": "事前審查品項代碼為KC01013230才可填寫"
  }, {
    "code": "P111",
    "display": "惡性肋膜間皮瘤(ipilimumab併用nivolumab 120mg)",
    "definition": "事前審查品項代碼「先申請KC00958229，再申請KC01013230」才可填寫"
  }, {
    "code": "P121",
    "display": "膽道癌(併用化療)",
    "definition": "事前審查品項代碼為KC01088229才可填寫"
  }, {
    "code": "P131",
    "display": "早期三陰性乳癌(併用化療)",
    "definition": "KC01025219(114年6月起擴增)"
  }, {
    "code": "P141",
    "display": "大腸直腸癌",
    "definition": "KC01025219(114年6月起擴增)"
  } ],
  "caseSensitive": true,
  "version": "1.0.5",
  "contact": [ {
    "name": "衛生福利部中央健康保險署",
    "telecom": [ {
      "value": "https://www.nhi.gov.tw",
      "system": "url"
    } ]
  } ]
}